BU-NOT-SET

CONTACT US
A CDMO’s insight into the pharma M&A landscape
  • Industry trends
Eyes
Insight
Recipharm’s continuous global support throughout the COVID-19 pandemic
  • Industry trends
Eyes
Insight
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics
Insight
  • Drug product
  • Manufacturing
Unlocking the potential of mRNA with robust lyophilisation strategies
Insight
  • Biologics
Advanced Bio Is Advancing AAV Production
Insight
  • Biologics
Advanced is advancing xRNA manufacturing
Insight
  • Drug product
  • Manufacturing
What are the innovations driving the future of sterile drug packaging?
Insight
  • Biologics
Revolutionising gene editing with end-to-end CDMO services
Insight
  • Biologics
Advanced Bio streamlines regulatory compliance
Insight
  • Biologics
Advanced Bio leads nucleic acid innovation